A new feature to IDS series, the commerical applications session is designed to examine the latest ways in which companies are using dendrimer technologies throughout several business environments, ranging from today’s use of dendrimer-based transfection agents and nano diagnostics to dendrimer-based anti-viral and imaging contrast agents. This new session will clearly illustrate the rapidly expanding role of dendrimers as crucial building blocks in the nanotechnology revolution.